Pfizer Inc. recalls 4.2% Sodium Bicarbonate Injection
FDA Class I
FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.
- Hazard
- Presence of Particulate Matter; identified as glass
- Products
-
- 4.2% Sodium Bicarbonate Injection
- Company
- Pfizer Inc.
- Where it was sold
-
Nationwide in the USA and Puerto Rico.
Nationwide
- Units affected
- 34000 Cartons
- About this recall
- 4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake Forst, IL 60045, NDC 0409-5534-24 (carton), 0409-5534-14 (case).